Geometry.Net - Health_Conditions: Tyrosinemia


Home - Health_Conditions - Tyrosinemia

e99.com Bookstore

Images

Newsgroups

1-20 of 92 1 | 2 | 3 | 4 | 5 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tyrosinemia: more detail

Tyrosinemia - A Bibliography and Dictionary for Physicians, Patients, and Genome Researchers by Philip M. Parker, 2007-07-19

Dietary management of inherited metabolic disease: Phenylketonuria, galactosemia, tyrosinemia, homocystinuria, maple syrup urine disease by Phyllis B Acosta, 1976

lists with details

Tyrosinemia
Information about tyrosinemia, a rare metabolic disorder. Includes lists of links to other support Category Health Conditions and Diseases Rare Disorders tyrosinemiaReaching out and connecting tyrosinemia families throughout the world ..Purpose To allow a forum for families to share experiences
http://groups.msn.com/tyrosinemia

Extractions: Recommend This Group to a Friend Welcome! This is the place for all people interested in connecting with others with Tyrosinemia. Tyrosinemia is an inborn error of metabolism in which the body can not effectively break down the amino acid tyrosine. Treatment varies depending on the specific type. A low protein diet may be required. The information provided is offered for general informational and educational purposes only. It is not offered as and does not constitute medical advice. In no way are any of the materials presented meant to be a substitute for professional medical care or attention by a qualified practitioner, nor should they be construed as such. Contact your physician if there are any concerns or questions. Click Here to Search This Site FastCounter by bCentral
Tyrosinemia-11
liver and renal functions are not affected. in tyrosinemiaI, the damage is not done by the build-up of tyrosine but by
http://www.icondata.com/health/pedbase/files/TYROSIN1.HTM

Extractions: Pediatric Database (PEDBASE) Discipline: MET Last Updated: 9/28/93 A disorder of tyrosine metabolism characterized by the build-up of tyrosine resulting in oculocutaneous lesions. risk factors: disorder first described in 1938 and connection to tyrosine metabolism established in 1973 appear during the first few months of life: lacrimation, photophobia, redness
Tyrosinemia
Some tyrosinemia links Look at these for the variety they represent
http://communities.msn.com/tyrosinemia/home.htm

Extractions: Recommend This Group to a Friend Welcome! This is the place for all people interested in connecting with others with Tyrosinemia. Tyrosinemia is an inborn error of metabolism in which the body can not effectively break down the amino acid tyrosine. Treatment varies depending on the specific type. A low protein diet may be required. The information provided is offered for general informational and educational purposes only. It is not offered as and does not constitute medical advice. In no way are any of the materials presented meant to be a substitute for professional medical care or attention by a qualified practitioner, nor should they be construed as such. Contact your physician if there are any concerns or questions. Click Here to Search This Site FastCounter by bCentral
TYROSINEMIA-I
Offers a definition of tyrosinemia-1, the epidemiology, pathogenesis, clinical features, investigations Category Health Conditions and Diseases Rare Disorders tyrosinemiaPediatric Database (PEDBASE); Discipline MET; Last Updated 5/18/94 tyrosinemiaI.DEFINITION INVESTIGATIONS 1. tyrosinemia. 1. Diagnostic.
http://www.icondata.com/health/pedbase/files/TYROSINE.HTM
EMedicine - Tyrosinemia : Article By Karl S Roth, MD
RichnerHanhart syndrome, transient tyrosinemia of the newborn, TTN, tyrosinemia I, tyrosinemia II, tyrosinemia III
http://www.emedicine.com/ped/topic2339.htm

Extractions: (advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Pediatrics Genetics And Metabolic Disease Last Updated: May 21, 2002 Rate this Article Email to a Colleague Synonyms and related keywords: hereditary infantile tyrosinemia, Richner-Hanhart syndrome, transient tyrosinemia of the newborn, TTN, tyrosinemia I, tyrosinemia II, tyrosinemia III AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials ... Bibliography Author: Karl S Roth, MD , Chair, Professor, Department of Pediatrics, Creighton University School of Medicine Karl S Roth, MD, is a member of the following medical societies: Alpha Omega Alpha American Academy of Pediatrics American Association for the Advancement of Science American College of Nutrition ... Sigma Xi , Society for Pediatric Research, and Southern Society for Pediatric Research Editor(s): Erawati Bawle, MD, FAAP, FACMG , Director, Division of Genetic and Metabolic Diseases, Children's Hospital of Michigan; Clinical Professor, Department of Pediatrics, Wayne State University School of Medicine;
Disease Category Listing (207): Tyrosinemia
CenterWatch Listing of Clinical Research Trials for tyrosinemia Clinical Trials tyrosinemia. There are no studies currently listed in this category on the CenterWatch web site.
http://www.centerwatch.com/studies/cat207.htm

Extractions: in this illness area This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listing updated: March 28, 2003 at 3:28:09 PM Patient Resources: [ Trial Listing Notification Services Drug Directories
Tyrosinemia
CLF Regional Offices. tyrosinemia. What is tyrosinemia? Hereditary tyrosinemia is a genetic inborn error of metabolism
http://www.liverkids.org.au/ftyrosinemia.htm

Extractions: This site is hosted by Netfirms Web Hosting WHAT IS TYROSINEMIA? Hereditary tyrosinemia is a genetic inborn error of metabolism associated with severe liver disease in infancy. The disease is inherited in an autosomal recessive fashion which means that in order to have the disease, a child must inherit two defective genes, one from each parent. In families where both parents are carriers of the gene for the disease, there is a one in four risk that a child will have tyrosinemia. About one person in 100 000 is affected with tyrosinemia globally. HOW IS TYROSINEMIA CAUSED? Tyrosine is an amino acid which is found in most animal and plant proteins. The metabolism of tyrosine in humans takes place primarily in the liver. Tyrosinemia is caused by an absence of the enzyme fumarylacetoacetate hydrolase (FAH) which is essential in the metabolism of tyrosine. The absence of FAH leads to an accumulation of toxic metabolic products in various body tissues, which in turn results in progressive damage to the liver and kidneys. WHAT ARE THE SYMPTOMS OF TYROSINEMIA?
NORD - Tyrosinemia, Hereditary
Offers the synonyms, a general discussion and further resources.
http://www.stepstn.com/cgi-win/nord.exe?proc=GetDocument&rectype=0&recnu
Tyrosinemia
tyrosinemia, tyrosinemia@groups.msn.com, Groups Home, , My Groups, , Language, , Help. tyrosinemia Websites. NORD/ Pediatrician's Guide tyrosinemia Type I Part1.
http://groups.msn.com/tyrosinemia/pictures
National Library Of Medicine
The synonyms of tyrosinemia 11, a summary and major features.
http://www.nlm.nih.gov/cgi/jablonski/syndrome_cgi?term=tyrosinemia II&field=
Katalog - Wirtualna Polska
Serwis Katalog w Wirtualna Polska S.A. pierwszy portal w Polsce.
http://katalog.wp.pl/DMOZ/Health/Conditions_and_Diseases/Rare_Disorders/Tyrosine
Tyrosinemia Management
tyrosinemia Background tyrosinemiaI is a rare but devastating metabolic disorderthat presents as severe liver disease at less than six months of age.
http://www.meadjohnson.com/metabolics/tyrosinemia.html

Extractions: Seattle, WA Tyrosinemia-I is a rare but devastating metabolic disorder that presents as severe liver disease at less than six months of age. If tyrosinemia-I is unrecognized and untreated, affected infants will die from liver failure within a few weeks or months following the onset of symptoms. A more chronic form of the disorder may lead to progressive, cirrhotic liver disease and a Fanconi-like renal syndrome, with loss of phosphate in the urine, rickets, and growth failure. Young children and older patients also may have repetitive bouts of neurologic crises. Among patients who do not die from their symptoms in early childhood, a chronic form of the disorder eventually leads to liver failure or hepatocarcinoma and death, usually before 10 years of age. Tyrosinemia is inherited as an autosomal recessive disorder. In the general population of the United States and Europe, the incidence is estimated to be 1 in 100,000 to 120,000 live births. Incidence is significantly higher in the province of Quebec, Canada, and in Norway and Finland. The highest incidence occurs in the Saguenay-Lac Saint-Jean region of Quebec, where 1 in 1,846 live births results in an affected child. Based on newborn screening, it has been estimated that 1 person in 25 within the SaguenayLac Saint-Jean population carries a common mutation responsible for tyrosinemia. In Norway and Finland, incidence may be as high as 1 in 60,000 live births.
Tyrosinemia
tyrosinemia type I is a rare genetic metabolic disorder characterized by lack of the enzyme fumarylacetoacetate
http://groups.msn.com/tyrosinemia/nordpediatriciansguidetyrosinemiatypeipart2.ms

Extractions: tyrosinemia tyrosinemia@groups.msn.com Groups Home My Groups Language Help ... Tools The Pediatricians Guide to Tyrosinemia Type I Tyrosinemia type I is a rare genetic metabolic disorder characterized by lack of the enzyme fumarylacetoacetate hydrolase (FAH), which is needed to break down the amino acid tyrosine. Failure to properly break down tyrosine leads to abnormal accumulation of tyrosine and its metabolites in the liver, resulting in severe liver disease. Metabolic diseases are disorders that affect the bodys ability to perform certain chemical processes such as turning food into energy or recycling waste from dead cells. Many metabolic disorders do not have noticeable signs or symptoms at birth, but can eventually cause serious physical problems if not detected and treated early. There are several types of tyrosinemia (types I, II, and III, as well as a transient form that disappears spontaneously). This booklet describes type 1, which is the most severe form.
Hereditary Tyrosinemia
The two most common inborn errors of tyrosine catabolism are hepatorenal tyrosinemia(tyrosinemia type I) and oculocutaneous tyrosinemia (tyrosinemia type II).
http://www.meadjohnson.com/metabolics/hereditarytyrosinemia.html

Extractions: Hypertyrosinemia can be caused by several conditions, including hereditary diseases of tyrosine catabolim. The two most common inborn errors of tyrosine catabolism are hepatorenal tyrosinemia (tyrosinemia type I) and oculocutaneous tyrosinemia (tyrosinemia type II). The two diseases are completely different clinically. Patients with hepatorenal tyrosinemia can develop a wide range of liver and kidney problems, as well as acute episodes of peripheral neuropathy. In oculocutaneous tyrosinemia, the symptoms are painful thickening of the cornea, hyperkeratosis of the palms and soles, and in some cases mental impairment. Despite these differences, the dietary management of infants and children with either condition centers on restriction of phenylalanine and tyrosine, the precursor amino acids of the abnormal metabolic pathway. Hepatorenal tyrosinemia is caused by a deficiency of fumarylacetoacetate hydrolase (FAH) (see Figure 1) and is inherited as an autosomal recessive trait. Although hepatorenal tyrosinemia is panethnic, almost half of all reported cases are from the Saguenay-Lac St-Jean region of Quebec, Canada, where the disease is common because of a complex founder effect.
Tyrosinemia
SEARCH OUR SITE. tyrosinemia (TYRO) Type I, II III An Amino Acid Disorder. Studiesshow that 1 of every 100,000 live births will have tyrosinemia.
http://www.savebabies.org/diseasedescriptions/tyrosinemia.htm
Tyrosinemia
tyrosinemia. Test. Pathology. Neonatal tyrosinemia and increased excretionof tyrosine and its metabolites are not uncommon in premature infants.
http://gucfm.georgetown.edu/welchjj/netscut/genetics/Tyrosinemia.html

Extractions: Neonatal tyrosinemia lethargy, difficulty swallowing, impaired motor activity, prolonged jaundice, and increased levels of galactosse, phenyalanine, histidine and cholesterol. Mild acidosis in about half of the infants. Type I acute form cabbage-like odor, failure to thrive, vomiting, diarrhea, hepatomegaly, fever, jaundice, edema, melena, and progressive liver disease, which can lead to death in the first year of life. Type I chronic form milder, chronic liver disease, renal tubular dysfunction (Fanconi syndrome), hypophosphatemic rickets. Death in the first decade of life. Type II an oculocutaneous syndrome, findings present in infancy or early childhood. Skin lesions begin with or after the eye lesions. Long term effects include conreal scarring and glaucoma. Mental retardation sometimes reported.
CLF Tyrosinemia
tyrosinemia What is tyrosinemia? Hereditary tyrosinemia is a genetic inborn errorof metabolism associated with severe liver disease in infancy.
http://www.liver.ca/english/liverdisease/tyrosenemia.html
Hereditary Tyrosinemia
tyrosinemia can be caused by several conditions, including hereditarydiseases of tyrosine catabolism. The two most common inborn
http://www.csmd.ca/tyrosinemia.htm

Extractions: Home Up Phenylketonuria Galactosemia ... Organic Acidemias [ Hereditary Tyrosinemia ] Tyrosinemia can be caused by several conditions, including hereditary diseases of tyrosine catabolism. The two most common inborn errors of tyrosine catabolism are Hepatorenal Tyrosinemia (Tyrosinemia Type I) and Oculocutaneous Tyrosinemia (Tyrosinemia Type II); these two diseases are clinically quite different. Type I Tyrosinemia can result in a wide range of liver and kidney problems. In Type II Tyrosinemia, the symptoms are painful thickening of the cornea, hyperkeratosis of the palms and soles, and in some cases mental impairment. The dietary management of patients with either condition centres on restriction of phenylalanine and tyrosine, the precursor amino acids of the abnormal metabolic pathway. http://communities.msn.com/tyrosinemia/home.htm - a website containing links to further resources on all types of Tyrosinemia.
Tyrosinemia
Some tyrosinemia links. Look at these for the variety they represent AmericanLiver Foundation. Children's Liver Alliance tyrosinemia links.
http://acadprojwww.wlu.edu/vol4/BlackmerH/public_html/xliberty/chem/tyro.html
Health Care Professionals' Guide To Newborn Screening - Tyrosinemia
tyrosinemia. Treatment The treatment for tyrosinemia is the dietary restrictionof phenylalanine, methionine, tyrosine and administration of the drug NTBC.
http://www.slh.wisc.edu/newborn/guide/tyrosinemia.shtml

Extractions: Tyrosinemia Autosomal recessive amino acid disorder caused by a deficiency in the fumarylacetoacetate hydrolase enzyme activity causing the build up of the amino acid tyrosine in the blood. Early detection and treatment is successful in preventing poor growth, liver damage, swelling of the legs, and inappropriate bleeding. 24 hours of age: Results are valid Confirmation: Immediate consult with a metabolic specialist at one of the states two metabolic treatment centers. Treatment: The treatment for tyrosinemia is the dietary restriction of phenylalanine, methionine, tyrosine and administration of the drug NTBC. Although this treatment regime is successful in delaying the clinical symptoms of tyrosinemia, the only effective long-term treatment is liver transplantation.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1-20 of 92 1 | 2 | 3 | 4 | 5 | Next 20